A SOLICITATION OF THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR SMALL BUSINESS INNOVATION RESEARCH (SBIR) CONTRACT PROPOSALS
Solicitation Number: PHS-2015-1
Agency: Department of Health and Human Services
Office: National Institutes of Health
Location: National Institute of Allergy and Infectious Diseases
Office: National Institutes of Health
Location: National Institute of Allergy and Infectious Diseases
|
:
PHS-2015-1
:
Solicitation
:
Added: Jul 31, 2014 2:29 pm
1. National Institutes of Health, Bethesda, MD 20892 and Centers for
Disease Control and Prevention, Atlanta, GA 30305 are soliciting
proposals from small business concerns that possess the research and
development (R&D) expertise to conduct innovative research that will
contribute toward meeting the program objectives of the agencies. U.S.
DEPARTMENT OF HEALTH AND HUMAN SERVICES (DHHS), THE NATIONAL INSTITUTES
OF HEALTH (NIH) AND THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
SMALL BUSINESS INNOVATIVE RESEARCH (SBIR) PROGRAM SOLICITATION PHS
2015-1 with a closing date on or about November 5, 2014, for receipt of
proposals, soon will be available electronically through the NIH Small
Business Research Funding Opportunities (http://sbir.nih.gov) Web site
and at fedbizopps.gov. The SBIR Phase I, Fast-Track, Direct to Phase II
Contract Solicitation will be available ONLY via electronic means.
Printed copies of the Solicitation will not be distributed. Potential
offerors are encouraged to check the NIH Small Business Research Funding
Opportunities Web site and fedbizopps.gov for updates on the program.
Any updates or corrections to the Solicitation will be posted there. The
purposes of the SBIR program are to: (a) stimulate technological
innovation in the private sector; (b) strengthen the role of small
business in meeting Federal research/research & development
(R/R&D) needs; (c) increase the commercial application of
Federally-supported research results; (d) foster and encourage
participation by socially and economically disadvantaged small business
concerns and women-owned business concerns; and improve the return on
investment from Federally-funded research for economic and social
benefits to the Nation. For purposes of the SBIR program, a small
business concern is any business concern that, on the date of award, (1)
is organized for profit, with a place of business located in the United
States, which operates primarily within the United States or which
makes a significant contribution to the United States economy through
payment of taxes or use of American products, materials or labor; (2) is
in the legal form of an individual proprietorship, partnership, limited
liability company, corporation, joint venture, association, trust or
cooperative, except that where the form is a joint venture, there must
be less than 50 percent participation by foreign business entities in
the joint venture; (3) more than 50% directly owned and controlled by
one or more individuals (who are citizens or permanent resident aliens
of the United States), other business concerns (each of which is more
than 50% directly owned and controlled by individuals who are citizens
or permanent resident aliens of the United States), or any combination
of these; OR more than 50% owned by multiple venture capital operating
companies, hedge funds, private equity firms, or any combination of
these. No single venture capital operating company, hedge fund, or
private equity firm may own more than 50% of the concern AND (4) has,
including its affiliates, no more than 500 employees. Following are the
research topics identified in the NIH/CDC SBIR Contract Solicitation
[PHS 2015-1]: NATIONAL INSTITUTES OF HEALTH (NIH) - NATIONAL CANCER
INSTITUTE (NCI): Vacutubes to Preserve the Viability of Circulating
Tumor Cells; Development of Advanced Culture Systems for Expansion of
Cancer Stem Cells; Development of Novel Therapeutic Agents That Target
Cancer Stem Cells; Cell-Free Nucleic Acid-Based Assay Development for
Cancer Diagnosis; Predictive Biomarkers of Adverse Reactions to
Radiation Treatment; Systemic Targeted Radionuclide Therapy For Cancer
Treatment; Validation of Mobile Technologies for Clinical Assessment,
Monitoring, and Intervention. NATIONAL CENTER FOR ADVANCING
TRANSLATIONAL SCIENCES (NCATS): Exploring the Potential of CRISPR/CAS
Genome-editing Tools; Assay Development for High-Throughput Screening of
Chemicals of Toxicological Concern; Simple and Robust Reaction Progress
Analyzer; Online Real Time Metals Analysis at Low ppm Level. NATIONAL
HEART, LUNG AND BLOOD INSTITUTE (NHLBI): Transcatheter Cerclage Mitral
Annuloplasty (SBIR-TT); Closure Devices for Transcaval Access to the
Abdominal Aorta; In-bore Defibrillation for Invasive MRI Cardiology
Procedures; Devices to Close Ductus Arteriosus in Premature Infants;
Therapeutic Delivery of ADP-ribosylarginine Hydrolase; Selective
Silencing of Stat3 Signaling to Treat Relapsed Disease After
Transplantation; Cellular Immunotherapy After Stem Cell Transplantation.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID):
Development of Novel Influenza Antivirals; Methods of Clinical Sample
Preparation for Rapid Detection of Bacterial Pathogens; Inhaled Delivery
of Clofazimine (CFZ) - An Important Anti-tuberculosis Drug; Simple,
Inexpensive Unit for Removing Cells from Small Amounts of Blood in
Resource-Limited Settings. NATIONAL INSTITUTE ON DRUG ABUSE (NIDA):
Mobile Technologies Extending Reach of Primary Care for
Substance-Use-Disorders. CENTERS FOR DISEASE CONTROL AND PREVENTION
(CDC) - CENTER FOR GLOBAL HEALTH (GCH): Diagnostic Tools to Support the
Elimination and Control of Neglected Tropical Diseases. NATIONAL CENTER
FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION (NCCDPHP): Optical
Character Recognition Software for Scanning Nutrition Facts Panel.
NATIONAL CENTER FOR EMERGING ZOONOTIC AND INFECTIOUS DISEASES (NCEZID):
Development of Nanoparticle Dengue Diagnostic Tests. NATIONAL CENTER
FOR HIV/AIDs, VIRAL HEPATITIS, STD, AND TB PREVENTION (NCHHSTP):
Yeast-derived Candidate of Hepatitis E Virus Vaccine; Multiplex Assay
for Simultaneous Detection of Hepatitis and Other Viruses; Improved
Antibody Preparation for Post-Exposure Prophylaxis Against Hepatitis A.
NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES (NCIRD):
Thermostable Dry Vaccine Formulation for Microneedle Administration;
Thermostable Oral Vaccines to Combat Enteric Diseases.2. NIH/CDC SBIR Contract Solicitation PHS 2015-1, including proposal forms, will be available electronically on/around August 15, 2014 through the NIH Small Business Research Funding Opportunities Web site and at fedbizopps.gov. (Note: The PHS 2014-2 Omnibus Solicitation of the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Administration for Children and Families for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) GRANT Applications, where investigator-initiated ideas are encouraged, is still open and is available at the same Web site noted above with a remaining due date of December 5, 2014.) To understand better the differences between grants and contracts, see Contracts vs. Grants: What's the difference? (http://grants.nih.gov/grants/funding/contracts_vs_grants.htm) LINKURL: http://grants.nih.gov/grants/funding/sbir.htm LINKDESC: National Institutes of Health Small Business (SBIR/STTR) Research Funding Opportunities. E-mail: sbir@od.nih.gov
Added: Aug 15, 2014 2:56 pm
Points of Contact: Office of Extramural Programs, Office of Extramural Research, National Institutes of Health, Phone 301-435-2688, sbir@od.nih.gov. Contracting Office Address: Office of Acquisitions 5601 Fishers Lane, Suite 300, MSC 9821 Bethesda, Maryland 20892-9821 Primary Point of Contact: Office of Extramural Programs, Office of Extramural Research, National Institutes of Healthsbir@od.nih.gov Phone: 301-435-2688
Please consult the list of document viewers if you cannot open a file.
Solicitation 1
Type:
Solicitation
Posted Date:
August 15, 2014
PHS2015-1.pdf (944.13 Kb)
Description: U.S. DEPARTMENT OF HEALTH
AND HUMAN SERVICES (HHS), THE NATIONAL INSTITUTES OF HEALTH (NIH) AND
THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) SMALL BUSINESS
INNOVATIVE RESEARCH (SBIR) PROGRAM
PROGRAM SOLICITATION PHS 2015-1 Amendment 1
Type:
Mod/Amendment
Posted Date:
September 11, 2014
Amendment_No._1_-_.pdf (35.19 Kb)
Description: PHS 2015-1, Amendment 1 -
The purpose of this amendment is to provide corrections and revisions
to Sections 3.1, 3.2, 6.4, 8.3, 9, 10, and 12 of the subject
solicitation.
Attachment_-_PHS2015-1_-_Amendment_One.pdf (824.18 Kb)
Description: Attachment: PHS 2015-1 - Amendment One
Amendment 2
Type:
Mod/Amendment
Posted Date:
October 17, 2014
Amendment_No._2.pdf (160.82 Kb)
Description: The purpose of this amendment is to provide revisions to Section 12 of the subject solicitation and to respond to questions.
:
Office of Acquisitions
6700 B Rockledge Room 3214 MSC7612 Bethesda, Maryland 20892-7612
:
:
|
No comments:
Post a Comment